Hyperfine, Inc.
General ticker "HYPR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $121.0M (TTM average)
Hyperfine, Inc. follows the US Stock Market performance with the rate: 8.0%.
Estimated limits based on current volatility of 4.9%: low 0.76$, high 0.84$
Factors to consider:
- Total employees count: 102 (-8.1%) as of 2025
- Countries other than US accounted for 49.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Limited operating history, Technology obsolescence, Customer retention, Regulatory and compliance, Labor/talent shortage/retention
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.76$, 1.78$]
- 2026-12-31 to 2027-12-31 estimated range: [0.78$, 1.82$]
Financial Metrics affecting the HYPR estimates:
- Positive: with PPE of -2.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Positive: -2.60 < Investing cash flow per share per price, % of -1.23
- Positive: Inventory ratio change, % of 0.07 <= 0.41
Short-term HYPR quotes
Long-term HYPR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $11.03MM | $12.89MM | $13.56MM |
| Operating Expenses | $59.15MM | $56.11MM | $50.65MM |
| Operating Income | $-48.12MM | $-43.22MM | $-37.09MM |
| Non-Operating Income | $3.88MM | $2.50MM | $1.51MM |
| R&D Expense | $22.49MM | $22.50MM | $17.45MM |
| Income(Loss) | $-44.24MM | $-40.72MM | $-35.57MM |
| Net Income(Loss)* | $-44.24MM | $-40.72MM | $-35.57MM |
| Stockholders Equity | $84.40MM | $49.04MM | $41.01MM |
| Inventory | $6.58MM | $5.83MM | $7.09MM |
| Assets | $94.20MM | $58.90MM | $55.26MM |
| Operating Cash Flow | $-41.81MM | $-38.77MM | $-27.95MM |
| Capital expenditure | $0.80MM | $0.38MM | $1.19MM |
| Investing Cash Flow | $-0.80MM | $-0.38MM | $-1.19MM |
| Financing Cash Flow | $0.17MM | $1.02MM | $27.50MM |
| Earnings Per Share** | $-0.62 | $-0.56 | $-0.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.